Flash Finance

Skybiotech Healthcare Ltd512036Corporate

Other Textile Products Latest results: Mar 2026 13 quarters of data
Consolidated Standalone
₹120.00
MCap ₹22 Cr
Skybiotech Healthcare Ltd — Stock analysis & AI research Skybiotech Healthcare Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹0 Cr
Sales · Mar 2026
₹-0 Cr
Operating Profit · Mar 2026
+75.0% YoY
—
OPM % · Mar 2026
₹0 Cr
Net Profit · Mar 2026
+105.0% YoY
₹0.05
EPS · Mar 2026
+104.8% YoY

📝 Skybiotech Healthcare Ltd — results explained

Quarter ended March 2026 (Q4 FY26)

Skybiotech Healthcare Ltd reported revenue of ₹0 crore for the quarter ended March 2026 (Q4 FY26).

The company swung to a net profit of ₹0 crore from a net loss of ₹0 crore a year earlier. Earnings per share (EPS) came in at ₹0.05.

Full year and trailing twelve months

For the full year FY26, Skybiotech Healthcare Ltd posted revenue of ₹0 crore, with a net loss of ₹0 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹0 crore with a net loss of ₹0 crore.

Valuation snapshot

At the current price of ₹120.00, 512036 has a market capitalisation of ₹22 crore.

Within the Other Textile Products industry, it is the 25th-largest of the 158 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 63.48%, public shareholders 36.53% of Skybiotech Healthcare Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹22 Cr
Current Price ?
₹120.0
P/E ?
N/A
Industry P/E ?
18.20
P/B ?
1.94
P/S ?
N/A
P/FCF ?
N/A
Enterprise Value ?
₹22 Cr
EV/EBITDA ?
-186.75
PEG ?
N/A
Earnings Yield ?
-0.5%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
N/A
OPM ?
N/A
Profit after tax (TTM) ?
₹-0 Cr
EPS (TTM) ?
₹-0.27
ROCE ?
-0.5%
ROE ?
-0.4%
ROA ?
-0.4%
Growth
Sales — latest qtr ?
₹0 Cr
PAT — latest qtr ?
₹0 Cr
YoY qtr sales growth ?
N/A
YoY qtr profit growth ?
105.0%
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
-4%
Financial Health
Debt ?
₹0 Cr
Debt to Equity ?
0.00
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
63.48%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-39.4%
Return 6 months ?
-22.9%

🗓️ Quarterly results (13 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026 YoY % QoQ %
Sales 0000000000000 — —
Operating Profit 0-0-0-0-0-0-00-0-0-0-0-0 +75.0% +83.3%
Other Income 00011000-00000 +110.0% —
Interest 0000000000000 — —
Depreciation 0000000000000 — —
Profit Before Tax 0-0011000-0-00-00 +104.2% +116.7%
Net Profit 0-0010000-0-00-00 +105.0% +116.7%
EPS 0.00-0.290.105.592.561.310.050.00-1.04-0.050.05-0.310.05 +104.8% +116.1%
OPM % — — — — — — — — — — — — — — —

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹0 Cr ₹0 Cr ₹0 Cr —
Operating Profit ₹-0 Cr ₹-0 Cr ₹-0 Cr -33.3%
OPM % — — — —
NPM % — — — —
Other Income ₹0 Cr ₹0 Cr ₹0 Cr -58.8%
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr —
Interest ₹0 Cr ₹0 Cr ₹0 Cr —
EBIT ₹-0 Cr ₹-0 Cr ₹-0 Cr -33.3%
PBT ₹0 Cr ₹-0 Cr ₹-0 Cr -162.5%
Tax — — — —
Net Profit ₹0 Cr ₹-0 Cr ₹-0 Cr -183.3%
EPS ₹0.32 ₹-0.26 ₹-0.26 -181.3%
Material Cost — — — —
Employee Cost — — — —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 1.041.921.921.92 +0.0%
Reserves 2.458.929.869.64 -2.2%
Borrowings 0.000.000.000.00 —
Other Liabilities 0.570.680.840.86 +2.4%
Total Liabilities 4.0611.5212.6212.42 -1.6%
Fixed Assets 0.010.000.000.00 —
CWIP 0.000.000.000.00 —
Investments 4.042.9312.4712.25 -1.8%
Other Assets 0.018.590.150.17 +13.3%
Total Assets 4.0611.5212.6212.42 -1.6%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity -0.37-1.340.300.00 -100.0%
Cash from Investing Activity 0.383.63-9.300.02 +100.2%
Cash from Financing Activity 0.006.130.550.00 -100.0%
Net Cash Flow 0.018.42-8.450.02 +100.2%
Free Cash Flow -0.37-1.340.300.00 -100.0%
CFO/OP 617%833%20%138% +590.0%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
ROCE % -0.83%0.14%-0.44%-0.51% -15.9%

👥 Shareholding (latest 4 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026 % Chg
Promoters 63.48%63.48%63.48%63.48% +0.0%
Public 36.52%36.53%36.52%36.53% +0.0%
No. of Shareholders 664615620610 -1.6%

⚖️ Peer comparison

Industry: Other Textile Products · top 25 of 158 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 540718 Aayush Art ₹126.90 2,013 25.8 217 8 5.1% 3.7% — — 259.6% 300.0%
2 539300 Sunrakshakk Industries ₹238.70 1,142 35.7 320 21 11.9% 6.5% 106.0% 140.4% 426.0% 973.3%
3 512233 Jaybharat Text ₹28.00 819 — 31 -39 -66.9% -126.0% -14.6% 50.5% 444.2% -56.3%
4 BORANA Borana Weaves ₹303.05 807 11.7 408 69 24.6% 16.9% — — 24.5% 35.0%
5 500264 Mafatlal Industries ₹111.61 806 13.8 3,574 59 1.8% 1.7% 37.9% -7.2% -24.0% -67.4%
6 532503 Rajapalayam Mills ₹833.60 701 6.2 1,014 125 13.5% 12.3% 4.9% 618.8% 38.2% 119.4%
7 533407 True Green ₹32.93 648 2.0 504 54 19.0% 10.7% 1130.4% 1700.0% 3157.1% —
8 SUMEETINDS Sumeet Industries ₹11.87 625 24.6 1,074 28 4.9% 2.6% 4.7% -79.8% 9.6% -85.7%
9 DCMSIL DCM Shriram ₹69.28 603 — 446 -17 3.3% -3.8% — — -4.9% -99.1%
10 522122 Voith Paper ₹2,392.05 599 25.3 208 42 27.2% 20.1% 9.8% 3.9% -1.5% 3.3%
11 502958 Lakshmi Mills ₹5,813.00 539 42.2 246 10 12.7% 3.9% -8.1% -232.3% 8.4% 114.1%
12 532893 VTM ₹69.88 486 82.2 398 9 6.3% 2.1% 8.0% -75.3% 36.7% -58.0%
13 533006 Birla Cotsyn ₹0.13 383 — 45 -17 -26.0% -37.7% — -102.2% — 52.7%
14 532090 Atvo Enterprises ₹4.50 379 157.5 6 0 -1.6% 3.1% 43.1% 75.0% 8.7% -16.7%
15 514316 Raghuvir Synthetics ₹127.20 370 — 209 -10 -0.0% -4.8% -23.3% -115.1% -56.4% -197.8%
16 KESORAMIND Kesoram Industries ₹11.84 368 — 265 -9 -21.7% -3.4% -76.8% -101.6% 27.2% 79.7%
17 512527 Super Sales ₹1,813.95 354 51.6 424 11 9.5% 2.5% 1.7% 302.3% 13.6% 411.5%
18 521113 Suditi Industries ₹13.11 310 6.5 110 10 12.8% 9.1% 27.1% 234.3% -39.3% -22.9%
19 514324 Omnitex Industries ₹155.00 309 45.1 4 1 -18.5% 34.4% 32.3% 16.0% 2607.1% 97.2%
20 VGL VARVEE GLOBAL ₹55.00 283 — 72 -20 -0.5% -27.4% 47.9% -17.2% 1601.8% -125.7%
21 SOMATEX Soma Textiles ₹76.49 260 25.7 81 10 -1.8% 12.1% 752.3% -85.8% 1213.2% 1933.3%
22 RNBDENIMS R&B Denims ₹8.88 254 11.3 483 21 7.8% 4.3% 27.0% -9.9% 16.3% -46.8%
23 514010 Rudra Ecovation ₹69.60 236 — 22 -5 -12.5% -20.3% 18.8% -23.7% -94.3% -41.5%
24 514318 Jattashankar Industries ₹38.00 231 9.1 165 2 1.3% 1.1% 1484.1% 185.7% — 734.8%
25 512036 Skybiotech Healthcare ₹145.00 22 — — -0 — — — -183.3% — 105.0%
❓ Frequently asked questions
What was Skybiotech Healthcare Ltd's revenue in Q4 FY26?
Skybiotech Healthcare Ltd reported revenue of ₹0 crore for the quarter ended March 2026 (Q4 FY26).
What was Skybiotech Healthcare Ltd's net profit in Q4 FY26?
The company swung to a net profit of ₹0 crore from a net loss of ₹0 crore a year earlier. Earnings per share (EPS) came in at ₹0.05.
What is 512036's market capitalisation and P/E ratio?
At the current price of ₹120.00, 512036 has a market capitalisation of ₹22 crore.
Who owns Skybiotech Healthcare Ltd? (shareholding pattern)
As of Mar 2026, promoters held 63.48%, public shareholders 36.53% of Skybiotech Healthcare Ltd.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI